AU6341696A - Early onset alzheimer's disease gene and gene products - Google Patents

Early onset alzheimer's disease gene and gene products

Info

Publication number
AU6341696A
AU6341696A AU63416/96A AU6341696A AU6341696A AU 6341696 A AU6341696 A AU 6341696A AU 63416/96 A AU63416/96 A AU 63416/96A AU 6341696 A AU6341696 A AU 6341696A AU 6341696 A AU6341696 A AU 6341696A
Authority
AU
Australia
Prior art keywords
gene
early onset
onset alzheimer
disease
gene products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63416/96A
Other languages
English (en)
Inventor
Eric H. Karran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Ltd
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd, SmithKline Beecham Corp filed Critical SmithKline Beecham Ltd
Publication of AU6341696A publication Critical patent/AU6341696A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU63416/96A 1995-06-28 1996-06-26 Early onset alzheimer's disease gene and gene products Abandoned AU6341696A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59095P 1995-06-28 1995-06-28
US000590 1995-06-28
PCT/US1996/011002 WO1997001573A2 (fr) 1995-06-28 1996-06-26 Genes et produits geniques de la maladie d'alzheimer a apparition precoce

Publications (1)

Publication Number Publication Date
AU6341696A true AU6341696A (en) 1997-01-30

Family

ID=21692159

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63416/96A Abandoned AU6341696A (en) 1995-06-28 1996-06-26 Early onset alzheimer's disease gene and gene products

Country Status (2)

Country Link
AU (1) AU6341696A (fr)
WO (1) WO1997001573A2 (fr)

Also Published As

Publication number Publication date
WO1997001573A2 (fr) 1997-01-16

Similar Documents

Publication Publication Date Title
AU5508798A (en) Diagnostic and therapeutic reagents for alzheimer's disease
AU4650096A (en) Neural thread protein gene expression and detection of alzheimer's disease
AU1407399A (en) Treatment for alzheimer's disease
AU5772196A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
HUP9801639A3 (en) Genetic sequences and proteins related to alzheimer's disease, and uses therefor
AU5772296A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU5772396A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
AU1189395A (en) Apolipoprotein e polymorphism and alzheimer's disease
GB9516059D0 (en) Novel genes and proteins
AU5993996A (en) Touch-readable product and associated process
AU4636993A (en) Diagnosing alzheimer's disease and schizophrenia
AU3092995A (en) Breast specific genes and proteins
GB9511439D0 (en) Gene product and method
AU6401696A (en) Early onset alzheimer's disease gene and gene products
AU5053296A (en) Pharmaceutical agents for the treatment of Alzheimer's disease
GB9509424D0 (en) "An improved product"
AU1405899A (en) Treatment for alzheimer's disease
AU6331996A (en) The erf genetic locus and its products
AU4290096A (en) Microencapsulation process and product
AU4862396A (en) Human obesity gene
AU5240896A (en) Marek's disease vaccine
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU6341696A (en) Early onset alzheimer's disease gene and gene products
AUPN115095A0 (en) Analysis of and compositions and methods for the treatment of disease